GR851499B - - Google Patents

Info

Publication number
GR851499B
GR851499B GR851499A GR850101499A GR851499B GR 851499 B GR851499 B GR 851499B GR 851499 A GR851499 A GR 851499A GR 850101499 A GR850101499 A GR 850101499A GR 851499 B GR851499 B GR 851499B
Authority
GR
Greece
Application number
GR851499A
Other languages
Greek (el)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR851499B publication Critical patent/GR851499B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR851499A 1984-06-21 1985-06-19 GR851499B (en, 2012)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH464684 1984-09-28

Publications (1)

Publication Number Publication Date
GR851499B true GR851499B (en, 2012) 1985-11-25

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851499A GR851499B (en, 2012) 1984-06-21 1985-06-19

Country Status (16)

Country Link
US (1) US4670551A (en, 2012)
EP (1) EP0165902B1 (en, 2012)
AR (2) AR242036A1 (en, 2012)
AU (1) AU582754B2 (en, 2012)
CA (1) CA1239388A (en, 2012)
DE (1) DE3569540D1 (en, 2012)
DK (1) DK173854B1 (en, 2012)
ES (2) ES8704967A1 (en, 2012)
FI (1) FI83225C (en, 2012)
GR (1) GR851499B (en, 2012)
HU (1) HU192232B (en, 2012)
IE (1) IE58050B1 (en, 2012)
IL (1) IL75569A (en, 2012)
NO (1) NO165496C (en, 2012)
NZ (1) NZ212492A (en, 2012)
PT (1) PT80663B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100384866C (zh) 1995-12-11 2008-04-30 G·D·瑟尔公司 制备7α-羧基9,11-环氧甾族化合物的方法和其中使用的中间体以及烯双键环氧化作用的一般方法
EP1148061B1 (en) * 1996-12-11 2007-10-17 G.D. Searle LLC. Epoxidation process
BR9714510A (pt) * 1996-12-11 2000-11-28 Searle & Co Processo e preparo de esteróides de 9,11-époxi e intermediários úteis dos mesmos
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
PL371128A1 (en) 2001-12-12 2005-06-13 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
ATE51233T1 (de) * 1983-08-17 1990-04-15 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Also Published As

Publication number Publication date
IE58050B1 (en) 1993-06-16
PT80663B (en) 1987-05-08
DE3569540D1 (en) 1989-05-24
FI83225C (fi) 1991-06-10
EP0165902A2 (de) 1985-12-27
NZ212492A (en) 1989-02-24
EP0165902B1 (de) 1989-04-19
IE851535L (en) 1985-12-21
AR245731A1 (es) 1994-02-28
FI83225B (fi) 1991-02-28
IL75569A (en) 1989-03-31
NO165496C (no) 1991-02-20
DK280085D0 (da) 1985-06-20
NO165496B (no) 1990-11-12
US4670551A (en) 1987-06-02
ES557112A0 (es) 1987-08-16
AU4397185A (en) 1986-01-02
DK280085A (da) 1985-12-22
ES8704967A1 (es) 1987-04-16
DK173854B1 (da) 2001-12-27
NO852501L (no) 1985-12-23
HUT38367A (en) 1986-05-28
FI852430L (fi) 1985-12-22
AU582754B2 (en) 1989-04-13
PT80663A (en) 1985-07-01
AR242036A1 (es) 1993-02-26
FI852430A0 (fi) 1985-06-19
IL75569A0 (en) 1985-10-31
HU192232B (en) 1987-05-28
EP0165902A3 (en) 1986-10-22
CA1239388A (en) 1988-07-19
ES544387A0 (es) 1987-04-16
ES8707737A1 (es) 1987-08-16

Similar Documents

Publication Publication Date Title
GR851499B (en, 2012)
AU2219783A (en, 2012)
AU2557584A (en, 2012)
BE900712A (en, 2012)
BG38294A1 (en, 2012)
BG39778A1 (en, 2012)
BG44718A1 (en, 2012)
BG44723A1 (en, 2012)
BG44737A1 (en, 2012)
BG44749A1 (en, 2012)
BG44806A1 (en, 2012)
BG44829A1 (en, 2012)
BG44830A1 (en, 2012)
BG44848A1 (en, 2012)
BG44917A1 (en, 2012)
BG44933A1 (en, 2012)
BG44935A1 (en, 2012)
BG45025A1 (en, 2012)
BG45054A1 (en, 2012)
BG45060A1 (en, 2012)
BG45079A1 (en, 2012)
BG45080A1 (en, 2012)
BG45091A1 (en, 2012)
BG45092A1 (en, 2012)
BG45094A1 (en, 2012)